2019 National Limb Girdle Muscular Dystrophy Conference

30 Aug 2019 - 2 Sep 2019

Chicago, Illinois

This is the first national conference dedicated to all forms of LGMD.

The mission of this conference is to provide momentum to emerging treatments.  It exists to demonstrate to venture capitalists and biotechs that the LGMD patient community is robust, mobilized, and ready to aggressively advocate for effective treatments that in development. The nation's leading neurologists in Limb Girdle Muscular Dystrophy will be present along with major biotech companies on the cutting edge of emerging research. The goal is to find treatments that are fast, effective, and safe for all forms of LGMD.  Limb Girdle Muscular Dystrophy is a very serious, debilitating form of muscular dystrophy that primarily affects the muscle groups of the hips, arms, and legs.  Many subtypes also affect cardiac and breathing muscles which may lead to premature death.  Though forms vary, most individuals will use a wheelchair or mobility scooter eventually due to loss of ambulation.

The conference unites everyone dealing with Limb Girdle Muscular Dystrophy so that we can find safe, effective treatments fast.  This conference is dedicated to bringing every patient into an active role seeking to find cures and treatments alongside doctors, biotech, and pharmaceutical companies.  Our conference allows individuals to hear from the experts on new, emerging treatments.

For more information, and to register, please go to the conference website.